Related by context. All words. (Click for frequent words.) 69 orally administered inhibitor 69 JAK inhibitor 68 HCV protease inhibitors 68 Anticalins 67 ENMD # 67 liposomal formulation 67 fluoroquinolone antibiotic 67 proteasome inhibitor 67 oral prodrug 67 IMiDs 67 selective androgen receptor modulators 66 IMiDs ® compound 66 delafloxacin 66 MEK inhibitors 66 selective kinase inhibitor 66 SARMs 66 proteins peptides 66 AKT inhibitor 66 HGS# 66 IMiDs ® 66 virus HCV protease inhibitor 66 LNP formulations 66 novel immunomodulatory 66 HCV protease inhibitor 66 antitumor effects 66 CYT# potent vascular disrupting 65 JAK inhibitors 65 direct thrombin inhibitors 65 PDE4 inhibitor 65 anticoagulant reversing agent 65 novel VDA molecule 65 ARIKACE ™ 65 IMiDs R 65 GERD migraine headaches 65 favorable pharmacokinetic profile 65 receptor tyrosine kinase inhibitor 65 AEG# 65 highly selective inhibitor 65 rxRNA 65 polymerase inhibitors 65 Myocet 65 Hsp# inhibitors 65 mTOR inhibitors 65 LHRH antagonists 65 pan HDAC inhibitor 65 microtubule inhibitor 65 preclinical efficacy 65 Anticalins R 65 MAGE A3 ASCI 65 Deforolimus 65 Nanobody ® 65 CD# monoclonal antibody 65 TPI ASM8 64 thetreatment 64 ADP receptor antagonist 64 antisense inhibitors 64 investigational humanized monoclonal antibody 64 HepDirect prodrug 64 Civacir 64 CCX# 64 cyclophilin inhibitors 64 antagomirs 64 CCR5 antagonist 64 SERMs 64 Locked Nucleic Acid LNA 64 novel peptide 64 nucleoside analog 64 Alfacell proprietary ribonuclease 64 radezolid 64 anti CD# antibodies 64 Onconase 64 pharmacodynamic markers 64 trastuzumab Herceptin R 64 Lenocta 64 neuroprotective properties 64 Azedra 64 Carfilzomib 64 resolvin 64 vinca alkaloid 64 protein kinase inhibitor 64 Anidulafungin 64 histone deacetylase inhibitor 64 Epothilones 64 Tß4 64 DiLA2 64 AAG geldanamycin analog 64 lexidronam injection 64 Ganetespib 64 PEG SN# 64 histone deacetylase HDAC inhibitor 64 ceftazidime 64 fusion enhancers 64 telaprevir VX 64 MORAb 64 HCV NS5B polymerase 63 beta lactam 63 interferon lambda 63 NNR Therapeutics 63 metaglidasen 63 VEGF inhibitors 63 anticancer therapeutics 63 MTP inhibitor 63 PSN# [002] 63 quinolone 63 QUADRAMET R 63 oral salmon calcitonin 63 therapeutic monoclonal antibody 63 relapsed MM 63 oral taxane 63 Preclinical studies suggest 63 Hsp# Inhibitor 63 Maribavir 63 docetaxel Taxotere R 63 Tarceva TM 63 IAP inhibitors 63 synthetic peptides 63 HuLuc# 63 HMG CoA reductase inhibitors 63 proteasome inhibitors 63 nucleoside reverse transcriptase inhibitor 63 Pertuzumab 63 bactericidal activity 63 docetaxel Taxotere ® 63 inhaled formulation 63 Tyrima 63 neratinib 63 siRNAs targeting 63 HGS ETR1 mapatumumab 63 RNA antagonist 63 PHX# 63 xenograft models 63 investigational hepatitis C 63 chemically modified siRNA 63 PRTX 63 Solorel TM 63 novel emulsion formulation 63 ALN HPN 63 Microplasmin 63 nucleoside analogs 63 HSP# inhibitor 63 novel histone deacetylase 63 HSP# inhibitors 63 P#X# antagonist 63 regorafenib 63 investigational therapies 63 SCY 63 Thiovir 63 antiarrhythmic agent 63 TKB# 63 Dapagliflozin 63 biophysical techniques 63 THALOMID 63 Rebif ® 63 inhibitor RG# 63 MGd 63 orally bioavailable 63 Squalamine 63 ALN TTR 63 Exelixis compounds 63 DuraSite 63 nucleotide analog 63 peptibody 63 IAP inhibitor 63 RG# ITMN 63 CORT # 63 cardio renal 63 CB1 antagonists 62 RNAi therapeutic targeting 62 small molecule activators 62 Xanafide 62 Talabostat 62 demonstrated antitumor activity 62 pharmacodynamic properties 62 Anticalins ® 62 evaluating tivozanib 62 lipopeptides 62 Rigel R# 62 SinuNase ™ 62 pomalidomide 62 TG# [003] 62 pathophysiological effects 62 Zysolin TM 62 Octreolin 62 ADI PEG 62 HQK 62 orally bioavailable mimics 62 antisense compounds 62 multicenter Phase II 62 EndoTAG TM 62 class mGluR5 inhibitor 62 Traficet EN 62 Vidaza ® 62 chimeric monoclonal antibody 62 Vidofludimus 62 CCR9 antagonist 62 NEUGENE antisense 62 Evoltra ® 62 oral antidiabetic 62 biologic therapeutics 62 retaspimycin 62 anti amnesic 62 targeted radiotherapeutic 62 Akt inhibitor 62 multicenter Phase III 62 HIV integrase inhibitors 62 PORxin TM 62 systemically administered 62 Archexin 62 AEGR 62 oxazolidinone 62 PSMA ADC 62 cleavable linker 62 preclinically 62 macrolide antibiotics 62 ESBA# 62 NXL# 62 SCH # 62 acetonide FA 62 topical formulations 62 kidney urologic 62 vascular disrupting agents 62 echinocandin 62 Symadex 62 Panzem R 62 FOLOTYN ® 62 RECOTHROM R 62 humanized monoclonal antibodies 62 bendamustine 62 AMPK activators 62 MKC# MKC# PP 62 alkylating agent 62 Anticalin ® 62 peptidic 62 selective immunoproteasome inhibitor 62 ALGRX 62 Dalbavancin 62 PDE# inhibitors 62 retapamulin 62 Sym# 62 intranasal delivery 62 polymerase inhibitor 62 TLR9 agonists 62 CD# CEA 62 non nucleoside inhibitor 62 PEGylated interferon 62 Nanobodies 62 CCR5 mAb 62 ALN PCS 62 nanopharmaceutical 62 endothelin antagonist 62 visilizumab 62 Omacetaxine 62 depsipeptide 62 Neulasta R 62 drug zotarolimus 62 torezolid 62 Tesmilifene 62 Fleximer 62 selective orally bioavailable 62 acyclovir Lauriad R 62 S/GSK# 62 PSN# [001] 62 Adnectin 62 darinaparsin ZIO 62 YONDELIS 62 Granulocyte Colony Stimulating Factor 62 BMS # 62 Daclizumab 62 Romidepsin 62 samarium Sm 62 R roscovitine 62 Xeloda ® 62 BAL# [001] 62 elotuzumab 62 Stapled Peptide 62 gemcitabine Gemzar 61 TLR9 agonist 61 Liprotamase 61 peptide conjugated 61 erlotinib Tarceva ® 61 sodium glucose cotransporter 61 Bezielle 61 sorafenib tablets 61 BCR ABL inhibitors 61 humanised monoclonal antibody 61 investigational monoclonal antibody 61 hyperphenylalaninemia HPA due 61 multi kinase inhibitor 61 Sudhir Agrawal D.Phil 61 trastuzumab emtansine T DM1 61 rxRNA TM compounds 61 selective estrogen receptor modulator 61 THR beta agonist 61 HIF PH inhibitors 61 prokinetic agent 61 vapreotide acetate 61 beta lactams 61 Selective Electrochemical Tumor Ablation 61 histone deacetylase HDAC 61 riociguat 61 PI3K/Akt pathway inhibitor 61 pharmacodynamic profiles 61 GAP #B# 61 anticancer agents 61 Friedreich Ataxia FRDA 61 NovaBay Aganocide compounds 61 diabetic neuropathic pain 61 zileuton 61 RNA antagonists 61 thiazolides 61 DermaVir Patch 61 JAK2 inhibitors 61 cMET 61 EndoTAG 61 DPP4 inhibitor 61 JVRS 61 PEG Interferon lambda 61 GMX# 61 Varespladib 61 taxane resistant 61 NEUGENE 61 lenalidomide dexamethasone 61 CG# [003] 61 BAL# [002] 61 RGB # 61 liposome encapsulated 61 PI3K/mTOR 61 anticancer agent 61 anti CD3 61 synthetic retinoid 61 oral antiviral 61 Virulizin ® 61 Trandolapril 61 CaPre TM 61 VDAs 61 cytotoxics 61 Elvitegravir 61 IMA# 61 Methylnaltrexone 61 FOLFOX6 chemotherapy regimen 61 EGFR HER2 61 Vidaza azacitidine 61 Debio 61 immunotherapeutic approaches 61 NEUGENE R 61 tubulin inhibitor 61 XmAb# 61 AzaSite Plus 61 factor Xa inhibitor 61 active moiety 61 immunotherapeutic vaccine 61 macrolide 61 tolerability pharmacokinetics 61 CEQ# 61 RESOLOR 61 Panzem R NCD 61 HCV polymerase 61 humanized monoclonal 61 affinity ligands 61 vidofludimus 61 antifolate 61 tigecycline 61 benzimidazole 61 peripherally acting 61 vivo potency 61 indibulin 61 Cerashield ™ 61 daptomycin 61 antitumoral 61 small molecule thrombopoietin 61 biodegradable implant 61 Tarvacin TM 61 efficacy tolerability 61 Interferon alpha 61 kinase inhibition 61 Pazopanib 61 non nucleoside 61 anti angiogenic agent 61 antiangiogenic agents 61 Tezampanel 61 peptides proteins 61 MEK inhibitor 61 CRLX# 61 A3 adenosine receptor 61 NanoTab 61 PRT# 61 cilengitide 61 Aurora kinase inhibitor 61 trastuzumab Herceptin ® 61 Guanilib 61 Tarmogen 61 Aganocide ® 61 Darinaparsin 61 Factor VIIa 61 epigenetic therapies 61 histone methyltransferases HMTs 61 busulfan 61 paclitaxel Taxol ® 61 selective antagonist 61 generation proteasome inhibitor 61 interferon gamma 1b 61 forodesine 61 antimetabolites 61 tezampanel NGX# 61 LEVAQUIN ® 61 adrenergic regulation 61 mertansine 61 OHR/AVR# 61 Fludara ® 61 candidate CRLX# 61 Aganocide 61 posaconazole 61 somatostatin 61 lomitapide 61 selective modulator 61 dihydrochloride 61 lymphoid tumors 61 oral picoplatin 61 chemotherapeutic drug 61 rNAPc2 61 Cerashield 61 anti miRs 61 anticancer therapies 61 Solazed TM 60 analgesic efficacy 60 oritavancin 60 oncolytic 60 delta isoform 60 Teriflunomide 60 oral Hsp# inhibitor 60 OMNARIS HFA 60 virus AAV 60 optical biosensors 60 PORxin TM platforms 60 CANCIDAS 60 OvaRex R 60 HDAC inhibitor 60 oral proteasome inhibitor 60 TAFA# 60 MOVIPREP R 60 targeted antifolate 60 sulfonylhydrazine class 60 PI3K inhibitor 60 2 inhibitor CYT# 60 cathepsin K inhibitor 60 drug ISA# 60 HGS ETR2 60 dexamethasone Decadron 60 metreleptin 60 TÎ ² 4 60 #ME# 60 DU #b 60 5 HT2A inverse 60 immunomodulator 60 Seliciclib 60 Zavesca R 60 GRNVAC1 60 macrolide antibiotic 60 molecular biomarkers 60 non nucleoside HCV 60 monoclonal antibody MAb 60 Vilazodone 60 2 methoxyestradiol 60 siRNA compounds 60 biologic pathway 60 Intravenous CP 60 Pruvel 60 XL# anticancer compounds 60 peptide antigens 60 ulimorelin 60 flavopiridol 60 Amrubicin 60 TRAIL receptor antibodies 60 TRISENOX ® 60 ocular formulation 60 pharmacodynamic parameters 60 polyketides 60 Belerofon 60 PROCHYMAL 60 Vascular Wrap TM 60 CTAP# Capsules 60 oral nucleoside analogue 60 reversible inhibitor 60 Silodosin 60 oral JAK1 60 beta lactamase inhibitor 60 hypoxia activated prodrug 60 anticancer compound 60 therapeutic mAbs 60 serotonin norepinephrine reuptake inhibitor 60 immunological diseases 60 nanoparticle aggregates 60 Tykerb lapatinib 60 siRNA therapeutic 60 TriRima 60 enzyme inhibitor 60 Sebivo 60 ritonavir boosted 60 AtuRNAi 60 Zalypsis 60 elvucitabine 60 bexarotene 60 Nanobody R 60 Ostabolin C TM 60 cisplatin gemcitabine 60 carbapenem 60 Nexavar ® 60 acting muscarinic antagonist 60 Initiates Phase II 60 oxidative stress inducer 60 Enhanze Technology 60 multitargeted 60 Aurexis 60 BioSilicon 60 intranasal formulation 60 ganetespib 60 OncoVEX 60 recombinant interferon 60 antiepileptics 60 stable nucleic acid 60 oral renin inhibitor 60 teriflunomide 60 fosbretabulin 60 INCB# [001] 60 Zoraxel TM 60 Irinotecan 60 selective androgen receptor modulator 60 Telbivudine 60 JAK2 inhibitor 60 lipid lowering agents 60 ZFPs 60 IMiD 60 synthetic siRNA 60 anti emetic therapy 60 sPLA2 60 CBLC# 60 tiapamil 60 gastro intestinal inflammation 60 octreotide acetate 60 Vidaza R 60 Zorbtive TM 60 Nanobodies ® 60 PROSTASCINT R 60 Blinatumomab 60 neuro inflammatory 60 biodefense pathogens 60 DOS# 60 Ophena TM 60 OMP #M# 60 targeting CD# 60 endogenous ligands 60 prostanoid 60 PORxin 60 small molecule tyrosine 60 preclinical xenograft models 60 Factor Xa inhibitor 60 pharmacokinetics pharmacodynamics 60 selective inhibitors 60 alvespimycin 60 varespladib 60 Zenvia ™ 60 investigational compounds 60 immune modulating 60 SPRIX ® 60 neurokinin 1 60 immunoconjugate 60 siRNA sequences 60 Atripla combines 60 TLR8 agonist 60 lipoglycopeptide 60 viral kinetics 60 Novavax VLP vaccine 60 dose regimens 60 injectable formulations 60 immune modulators 60 GSOs 60 dosage regimens 60 NTDDS 60 Oracea TM 60 endothelin receptor antagonists 60 adecatumumab MT# 60 KL4 surfactant 60 Kosan dependence 60 ProNAi 60 MCSP respectively 60 sorafenib Nexavar 60 Phase 1b trial 60 anti secretory 60 Initiates Enrollment 60 NeuroSTAT ® 60 derivatives Radilex TM 60 vorinostat 60 immunomodulating 60 Hsp# inhibition 60 thrombopoietin 60 blinded randomized placebo controlled 60 5 HT3 antagonist 60 Reports Preclinical Data 60 castrate resistant prostate cancer 60 humanized antibodies 60 thalidomide Thalomid 60 KSP inhibitor 60 Presents Preclinical 60 glucokinase activator 60 antidiabetic 60 NS#/#A protease 60 Nanobody 60 ARRY # 60 EGFR tyrosine kinase inhibitors 60 TNF alpha antagonist 60 platform HDL Mimetic 60 CR# vcMMAE 60 herpetic keratitis 60 Maxy G# 60 Clonicel 60 anidulafungin 60 p# biomarker 60 mTOR mammalian target 59 torezolid phosphate 59 potent antiproliferative 59 myelofibrosis polycythemia vera 59 NS5b 59 Panzem 59 potency selectivity 59 ART# 59 CTA# 59 Viprovex TM 59 GVAX ® 59 EOquin TM phase 59 Oral NKTR 59 nanomolar 59 epithelial tumors 59 macrocycles 59 Ceflatonin 59 TKM ApoB 59 rheumatoid arthritis psoriatic arthritis 59 INT# [002] 59 small molecule defensin 59 lymphoma subtypes 59 plasma kallikrein inhibitor 59 metabolite identification 59 gastrointestinal disorders ATI 59 DCCR 59 OncoVEX GM CSF 59 pegylated alpha interferon 59 BMS# 59 fluoroquinolone resistance 59 anti fibrotic 59 adipiplon 59 telomerase inhibitor 59 nitric oxide donating 59 subtype selective 59 lumiliximab 59 YONDELIS R 59 sulodexide 59 CA4P 59 Perifosine 59 evaluating REVLIMID 59 Apoptone 59 diarrhea predominant irritable 59 obatoclax 59 Relivar 59 mitiglinide 59 epothilone 59 recombinant fusion 59 cytokine refractory 59 Personalized Immunotherapy 59 tezampanel 59 Kahalalide F 59 Hsp# inhibitor 59 XL# XL# 59 vascular disrupting agent 59 Fosphenytoin 59 pharmacokinetic equivalence 59 echinocandins 59 isoform selective 59 beta lactam antibiotic 59 epothilones 59 investigational protease inhibitor 59 LEP ETU 59 fluoropyrimidine 59 ON #.Na 59 induced macular edema 59 immuno modulatory 59 radiolabeled monoclonal antibody 59 nucleoside tide 59 GIPET 59 Dasatinib 59 NASDAQ ABII 59 Amplimexon 59 Zybrestat 59 Cloretazine 59 HCV protease 59 Soliris eculizumab 59 opioid fentanyl 59 sapacitabine CYC# 59 davunetide intranasal AL 59 vitro cytotoxicity 59 HDAC Inhibitor 59 bortezomib Velcade 59 azoles 59 cytoprotective 59 oncolytic viruses 59 pharmacodynamic profile 59 clinically validated targets 59 TRX1 59 Vascugel 59 selective receptor agonist 59 adenoviral 59 AGHD 59 antineoplastic 59 Insegia 59 Cancidas 59 candidates Azedra TM 59 IgG1 antibodies 59 therapeutic monoclonal antibodies 59 effector function 59 THALOMID ® 59 vitro assay 59 staphylococcal vaccine 59 ETBs 59 metabonomics 59 Initiates Clinical Trial 59 safety tolerability pharmacokinetic 59 phase IIa clinical 59 milatuzumab 59 Cethrin R 59 soft gelatin capsule 59 Lubiprostone 59 HDAC enzymes 59 LY# [003] 59 Sapacitabine 59 XL# XL# XL# XL# 59 highly selective endothelin 59 SAR# [002] 59 mda 7 59 TLR antagonists 59 oral formulations 59 daunorubicin 59 Nilotinib 59 nucleoside analogues 59 faropenem 59 topical gel containing 59 CINQUIL 59 volociximab 59 Pafuramidine 59 COLAZAL R 59 ketolide antibiotic 59 PXD# 59 poly ethylene glycol PEG 59 FGFR 59 RLY# 59 delipidation 59 REMINYL ® 59 PI3K inhibitors 59 DiLA2 Platform 59 beta 1a 59 HCV replicon 59 Vfend 59 tyrosine kinase inhibitor TKI 59 dirucotide MBP# 59 cytostatic 59 Macrolide 59 pertuzumab 59 protease inhibitor PI 59 Saforis 59 antiviral efficacy 59 Raltegravir 59 aurora kinase inhibitor 59 bevacizumab Avastin ® 59 TELINTRA 59 thymalfasin 59 Pathway Inhibitor 59 agent VDA 59 iobenguane 59 intradermal injection 59 ferric citrate 59 Gonal f ® 59 Phase Ib II 59 Synavive ™ 59 Radezolid 59 AQ4N 59 angiotensin receptor blocker ARB 59 placebo controlled Phase III 59 Degarelix 59 antithrombotic agents 59 receptor inhibitor 59 renin inhibitors 59 Orally administered 59 prucalopride 59 alpha interferons 59 phase IIb clinical 59 5 FU leucovorin 59 XmAb ™ 59 PDX pralatrexate 59 Angiolix 59 LEX System 59 Affibody ® molecules 59 entinostat 59 virosome 59 Aplidin 59 bicifadine 59 SNT MC# 59 renin inhibitor 59 delta gamma agonist 59 radiation sensitizer 59 immunomodulators 59 DXL TM 59 mocetinostat MGCD# 59 compound AEZS 59 sunitinib malate 59 TBC# 59 metastatic neuroendocrine tumors 59 dAbs 59 #HT#A 59 MT#/MEDI-# 59 Nasulin ™ 59 familial amyloidotic polyneuropathy FAP 59 cationic lipid 59 Protelos 59 Fc fusion protein 59 PS# [001] 59 DsiRNA 59 anticancer activity 59 Prodarsan ® 59 MKC# MT 59 IRX 2 59 Vaxfectin 59 c Raf kinase 59 Solazed 59 calcineurin inhibitors 59 mTOR inhibition 59 brostallicin 59 mitogen activated ERK kinase 59 anti tubercular 59 Altastaph 59 antiproliferative effects 59 antimitotic 59 TLR agonists 59 immune stimulatory 59 Initiates Clinical 59 synthetic analogues 59 Anavex #-# 59 long acting muscarinic 59 Resten NG 59 calcipotriene 59 BACcel ™ system 59 CYC# 59 PD LID 59 topical ophthalmic 59 XP# XP# 59 liposomal delivery 59 tubulin inhibitors 59 pharmacokinetic parameters 59 JAK Inhibitor 59 epoetin alpha 59 DermaPrep 59 Marqibo TM 59 GFT# 59 Bicifadine 59 immatics 59 HepeX B TM 59 pharmacologically active isomer 59 beta interferons 59 BRAF kinase 59 selective inhibition 59 Campath ® 59 tyrosine kinase inhibitor 59 Completes Patient Enrollment 59 ZADAXIN ® 59 BEXXAR Therapeutic Regimen 59 liposomal 59 Aclidinium 59 cyclic peptide 59 EndoTAG TM -1 59 Protein Kinase C 59 CLORETAZINE TM VNP#M 59 insulin sensitizer 59 anticancer compounds 59 Shigamabs ® 59 PEGylated interferon beta 1a 59 Nektar pulmonary 59 transfection reagents 59 immune modulatory 59 IGF 1R inhibitor 59 Imprime PGG 59 vaccine GRNVAC1 58 axitinib 58 Cardiotoxicity 58 TransVax ™ 58 pharmacokinetic characteristics 58 genotypic resistance 58 antineoplastic agents 58 velafermin 58 Plasmin 58 interferon IFN 58 HCD# [002] 58 molecules peptides 58 Mitoxantrone 58 lapatinib Tykerb 58 ganaxolone 58 capsule formulation 58 mTOR inhibitor 58 PNP inhibitor 58 antitumor effect 58 catalytic antioxidant compounds 58 personalized immunotherapy 58 LEUKINE 58 HIV integrase inhibitor 58 pramlintide metreleptin combination 58 siRNA therapeutics 58 compound ITMN 58 Aviptadil 58 oral candidiasis 58 mucosal vaccines 58 POTELLIGENT ® 58 dopamine D2 58 parenterally administered 58 selective inhibitor 58 somatostatin analogue 58 Pharmos proprietary 58 Cytotoxic 58 Systemic Delivery 58 glucagon receptor 58 S1P antibody 58 GPCR targets 58 trodusquemine 58 activin receptor type 58 Elagolix 58 anti angiogenic agents 58 subcutaneous formulation 58 peptidomimetic 58 NP2 Enkephalin 58 cannabinor 58 topical dermatology 58 liposomal formulations 58 novel prodrug 58 MoxDuo 58 RezularTM 58 Curaxin 58 seliciclib CYC# 58 M2 subunit 58 GVAX cancer 58 PrevOnco ™ 58 patented Bioral 58 Small Molecule 58 splice variants 58 humanized anti 58 Tamibarotene 58 orally dosed 58 Genz # 58 Vaxfectin R 58 Cloretazine R 58 assay detects 58 pharmacokinetics PK 58 phase III isavuconazole 58 R sorafenib tablets 58 #beta HSD 1 58 potently inhibit 58 AVE# 58 pegylated 58 SAR# [004] 58 tecarfarin 58 IgG1 antibody 58 ibudilast 58 liposomal doxorubicin 58 myeloproliferative disorders 58 CINTREDEKIN BESUDOTOX 58 estrogen receptor modulators 58 PPAR gamma agonists 58 Phase IIa trials 58 5 HT6 receptor 58 paclitaxel Taxol 58 Naproxcinod 58 Peginterferon alfa 2b 58 Biochronomer 58 alpha 2A 58 BCR ABL inhibitor 58 relapsing multiple sclerosis 58 defensin mimetic antibiotic 58 active comparator 58 K ras mutations 58 Adnectins 58 EZN 58 small molecule modulators 58 Contramid 58 biodefense countermeasure 58 miconazole Lauriad ® 58 Vandetanib 58 Olaparib 58 Golimumab 58 immunotoxins 58 nanoviricides 58 tanespimycin 58 novel orally bioavailable 58 AIR# [001] 58 dermatological diseases 58 brain penetrant 58 humanized monoclonal antibody